400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / HCV / VCH-916
CAS No.: 1200133-34-1
VCH-916 is a nonnucleoside HCV NS5B polymerase inhibitor.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00623649 | HCV Infection | Phase 1 | Completed | - | United States, Texas ... more >> The Liver INstitute at Methodist Dallas Dallas, Texas, United States, 75208 Alamo Medical Research San Antonio, Texas, United States, 78215 Canada, Ontario Ottawa Hospital - General Campus Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Royal Victoria Hospital Montréal, Quebec, Canada, H3A 1A1 Puerto Rico Fundacion de Investigacion de Diego Santurce, Puerto Rico, 00909 Collapse << |
实验方案
技术信息
CAS号 | 1200133-34-1 | 储存条件 |
|
|
分子式 | C26H36KNO4S | 运输 | 蓝冰 | |
分子量 | 497.73 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00623649 | HCV Infection | Phase 1 | Completed | - | United States, Texas ... more >> The Liver INstitute at Methodist Dallas Dallas, Texas, United States, 75208 Alamo Medical Research San Antonio, Texas, United States, 78215 Canada, Ontario Ottawa Hospital - General Campus Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Royal Victoria Hospital Montréal, Quebec, Canada, H3A 1A1 Puerto Rico Fundacion de Investigacion de Diego Santurce, Puerto Rico, 00909 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网